This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 5 EPO patents. Top assignees: Vyzkumny Ustav Veterinarniho Lekarstvi, V.v.i., Apigenex S.r.o., Imuthes Limited. Active years: 2014-2022.
Location History:
- Praha, CZ (2016)
- Prague, CZ (2014 - 2022)
Company Filing History:
3 out of 3 
1 out of 1 
1 out of 1 
Years Active: 2014-2022
Title: Miroslav Ledvina: Innovator in Liposomal Systems
Introduction
Miroslav Ledvina is a prominent inventor based in Prague, Czech Republic. He has made significant contributions to the field of biochemistry, particularly in the development of liposomal systems. With a total of 3 patents, his work focuses on innovative methods and compounds that enhance drug delivery systems.
Latest Patents
Ledvina's latest patents include groundbreaking inventions such as aminooxylipids for the construction of self-assembling liposomal systems. These aminooxylipids are characterized by a general formula that allows for subsequent modification by biologically functional molecules. His method of preparation involves the acylation of specific diamines with symmetrically branched fatty acids, leading to the creation of N-Boc-aminolipids. Another notable patent involves lipopolyamines of spermine type, which are designed for constructing liposomal transfection systems. These innovations provide new avenues for developing polycationic liposomal drug carriers.
Career Highlights
Throughout his career, Miroslav Ledvina has worked with various research institutions, including the Veterinary Research Institute and Imuthes Limited. His expertise in biochemistry and liposomal technology has positioned him as a key figure in the field.
Collaborations
Ledvina has collaborated with notable colleagues such as Jaroslav Turanek and Zina Korvasova. Their combined efforts have contributed to advancements in liposomal drug delivery systems.
Conclusion
Miroslav Ledvina's innovative work in liposomal systems and drug delivery has made a significant impact in the field of biochemistry. His patents reflect a commitment to advancing medical technology and improving therapeutic outcomes.